Title of article - SIMBOSPROST: Prevalence of metabolic syndrome and osteoporosis in prostate cancer patients treated with radiotherapy and androgen deprivation therapy: A multicentre, cross-sectional study.
Abstract
To assess the prevalence of metabolic syndrome (MetS) and osteoporosis in patients with prostate cancer (PCa) treated with radical radiotherapy (RT) with or without androgen deprivation therapy (ADT).
CLICK HERE for Full article Click button above to go to original article link with complete article details for SIMBOSPROST: Prevalence of metabolic syndrome and osteoporosis in prostate cancer patients treated with radiotherapy and androgen deprivation therapy: A multicentre, cross-sectional study.
Please CLICK HERE to discuss with us on facebook about this article.
Click below for Details of research Institute
Department of Radiation Oncology, Rey Juan Carlos Hospital, Madrid, Spain.
Details of Journal for SIMBOSPROST: Prevalence of metabolic syndrome and osteoporosis in prostate cancer patients treated with radiotherapy and androgen deprivation therapy: A multicentre, cross-sectional study.
Journal Title - Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in PoznanÌ and Polish Society of Radiation Oncology
ISSN - 1507-1367
Volume - 20
Issue - 5
Publish date - -
Language - eng
Country - Netherlands
No comments:
Post a Comment